Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26F5X61
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,484
Award facts
- Contract value 100% obligated
- $16,484.08 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,484.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Cosentyx (secukinumab) 300mg dose auto-injector pens on January 13, 2026, with an ultimate completion date of January 14, 2026. This contract was competitively awarded with no set-aside designation and represents performance at the contractor's location in Conshohocken, Pennsylvania. The award is executed as a delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for pharmaceutical and medical supply deliveries to support military healthcare programs globally.
Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The supply of this specialty pharmaceutical through DLA's medical supply chain supports treatment needs across military treatment facilities and veterans' healthcare programs. AmerisourceBergen Drug Corp, as the child entity of Cencora, Inc., maintains a significant role in federal pharmaceutical procurement and has demonstrated capability to fulfill specialized medical supply requirements through its extensive portfolio of competitively awarded contracts with federal health agencies.
Quick answers
Who was awarded contract SPE2DR26F5X61?
SPE2DR26F5X61 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F5X61 worth?
The government has obligated $16,484 on SPE2DR26F5X61.
Is contract SPE2DR26F5X61 an order under another contract?
Yes. SPE2DR26F5X61 is a delivery order under SPE2DR25D3101, an indefinite delivery contract.
Was contract SPE2DR26F5X61 competed?
The extent of competition for SPE2DR26F5X61 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award